These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19407441)

  • 41. Harnessing economic drivers for successful clinical implementation of pharmacogenetic testing.
    Deverka PA; McLeod HL
    Clin Pharmacol Ther; 2008 Aug; 84(2):191-3. PubMed ID: 18679180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of race/ethnicity, sex, and social circumstances on coronary revascularization preferences: a vignette comparison.
    Barnhart JM; Wassertheil-Smoller S
    Cardiol Rev; 2006; 14(5):215-22. PubMed ID: 16924161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interest and attitudes of patients, cancer physicians, medical students and cancer researchers towards a spectrum of genetic tests relevant to breast cancer patients.
    Ngoi N; Lee SC; Hartman M; Khin LW; Wong A
    Breast; 2013 Feb; 22(1):47-52. PubMed ID: 22560561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials.
    Fabbri C; Zohar J; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():36-44. PubMed ID: 29777729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and ethical considerations in pharmacogenetic testing: views of physicians in 3 "early adopting" departments of psychiatry.
    Hoop JG; Lapid MI; Paulson RM; Roberts LW
    J Clin Psychiatry; 2010 Jun; 71(6):745-53. PubMed ID: 20361898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research.
    Daud ANA; Bergsma EL; Bergman JEH; De Walle HEK; Kerstjens-Frederikse WS; Bijker BJ; Hak E; Wilffert B
    BMC Pregnancy Childbirth; 2017 Apr; 17(1):120. PubMed ID: 28410576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knowledge and attitudes regarding expanded genetic carrier screening among women's healthcare providers.
    Ready K; Haque IS; Srinivasan BS; Marshall JR
    Fertil Steril; 2012 Feb; 97(2):407-13. PubMed ID: 22137493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Racial and ethnic disparities in care: the perspectives of cardiologists.
    Lurie N; Fremont A; Jain AK; Taylor SL; McLaughlin R; Peterson E; Kong BW; Ferguson TB
    Circulation; 2005 Mar; 111(10):1264-9. PubMed ID: 15769767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knowledge and attitudes of emergency department patients regarding radiation risk of CT: Effects of age, sex, race, education, insurance, body mass index, pain, and seriousness of illness.
    Takakuwa KM; Estepa AT; Shofer FS
    AJR Am J Roentgenol; 2010 Nov; 195(5):1151-8. PubMed ID: 20966321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Racial distribution of patient population and family physician endorsed importance of screening patients for inherited predisposition to cancer.
    Gramling R; Clarke J; Simmons E
    J Health Care Poor Underserved; 2009 Feb; 20(1):50-4. PubMed ID: 19202245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory.
    Haga SB; Liu Y
    Pharmacogenomics; 2019 Jun; 20(8):581-587. PubMed ID: 31190624
    [No Abstract]   [Full Text] [Related]  

  • 53. Willingness to pay for genetic testing: a study of attitudes in a Canadian population.
    Ries NM; Hyde-Lay R; Caulfield T
    Public Health Genomics; 2010; 13(5):292-300. PubMed ID: 19864872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing the impact of pre-test education on patient knowledge, perceptions, and expectations of pharmacogenomic testing to guide antidepressant use.
    Sloat NT; Yashar BM; Ellingrod VL; Ward KM
    J Genet Couns; 2022 Dec; 31(6):1373-1382. PubMed ID: 35900228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Professional perspectives about pharmacogenetic testing and managing ancillary findings.
    Haga SB; Tindall G; O'Daniel JM
    Genet Test Mol Biomarkers; 2012 Jan; 16(1):21-4. PubMed ID: 21770772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
    Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
    Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Consultations in general practice and at an Aboriginal community controlled health service: do they differ?
    Larkins SL; Geia LK; Panaretto KS
    Rural Remote Health; 2006; 6(3):560. PubMed ID: 16863398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacogenomic testing: knowing more, doing better.
    Lunshof JE; Gurwitz D
    Clin Pharmacol Ther; 2012 Mar; 91(3):387-9. PubMed ID: 22343816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Background and methodology of the Osteopathic Survey of Health Care in America 2010 (OSTEOSURV 2010).
    Licciardone JC; Kearns CM; Ruggiere P
    J Am Osteopath Assoc; 2011 Dec; 111(12):670-84. PubMed ID: 22182953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
    Tong S; Hughes K; Oldenburg B; Del Mar C
    Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.